Advertisement
Research Article

Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis

  • Dick Menzies mail,

    dick.menzies@mcgill.ca

    Affiliation: Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute & Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Canada

    X
  • Andrea Benedetti,

    Affiliation: Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute & Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Canada

    X
  • Anita Paydar,

    Affiliation: Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute & Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Canada

    X
  • Ian Martin,

    Affiliation: Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute & Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Canada

    X
  • Sarah Royce,

    Affiliation: University of California at San Francisco, San Francisco, California, United States of America

    X
  • Madhukar Pai,

    Affiliation: Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute & Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Canada

    X
  • Andrew Vernon,

    Affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Christian Lienhardt,

    Affiliation: International Union against Tuberculosis and Lung Diseases, and Institut de Recherche pour le Développement, Paris, France

    X
  • William Burman

    Affiliation: Denver Public Health, Denver, Colorado, United States of America

    X
  • Published: September 15, 2009
  • DOI: 10.1371/journal.pmed.1000146

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis

Dick Menzies, Andrea Benedetti, Anita Paydar, Sarah Royce, Madhukar Pai, William Burman, Andrew Vernon, Christian Lienhardt
Research Article | published 15 Sep 2009 | PLOS Medicine
doi:10.1371/journal.pmed.1000150